Bowes, Christa D.
Lien, Lillian F.
Butler, Javed
Article History
Received: 13 December 2018
Accepted: 21 May 2019
First Online: 24 July 2019
Duality of interest
: LFL has served as a consultant for Tandem, Novo Nordisk, Merck, Eli Lilly and Sanofi and receives royalties from Springer Inc. JB has received research support from the National Institutes of Health, Patient Centered Outcomes Research Institute and the European Union and serves as a consultant for Adrenomed, Amgen, Array, AstraZeneca, Bayer, Berlin Cures, Boehringer Ingelheim, Bristol Myers Squib, CVRx, G3 Pharmaceutical, Janssen, Lantheus, Luitpold, Medtronic, Merck, Novartis, Relypsa, Roche, Sanofi, StealthPeptide, SC Pharma, Vifor and ZS Pharma. CDB reports no duality of interest associated with this manuscript.
Free to read: This content has been made available to all.